Referenser till artikeln Parkinsonspatient på bättringsvägen
av Hanne Koplev

1) Aarhus privatklinik for holistisk medicin, http://www.holistic-medicine.dk/index.html <http://www.holistic-medicine.dk/index.html>
2) www.melisa.org <http://www.melisa.org/>
3) Meara, Jolyon et al. ”Accuracy of diagnosis in patients with presumed Parkinson's disease.” Age and Ageing, Vol. 28, March 1999, pp. 99-02. http://www.yourhealthbase.com/database/a91e.htm <http://www.yourhealthbase.com/database/a91e.htm>
4) http://www.michaeljfox.org/news/article.php?id=287 <http://www.michaeljfox.org/news/article.php?id=287> http://www.michaeljfox.org/newsEvents_michaelInTheNews.cfm <http://www.michaeljfox.org/newsEvents_michaelInTheNews.cfm>
5) Montgomery EB Jr, ”Heavy metals and the etiology of Parkinson's disease and other movement disorders.” Toxicology. 1995-03-31;97(1-3):3-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7716790&dopt=Abstract <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7716790&amp;dopt=Abstract> 6) Thiruchelvam, Mona et al. ”The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease.” J Neuroscience, 2000-12-15, 20(24):9207-9214. http://www.jneurosci.org/cgi/content/abstract/20/24/9207 <http://www.jneurosci.org/cgi/content/abstract/20/24/9207>
7) ”Parkinson's Disease Research at NIEHS”http://www.legalhelpcenters.com/Manganese-Research-Lawyer_513.html ,
http://www.niehs.nih.gov/oc/factsheets/parkinson/research.htm
8)Godfrey ME, , Wojcik DP, Krone CA. Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity. J Alzheimers Dis. 2003 Jun;5(3):189-95.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12897404&dopt=Abstract

Referenser till artikeln Glutationterapi vid Parkinsons
av Helene Sandström

1) Perlmutter, David. ”New Advances in Parkinson's Disease.” Townsend Letter for Doctors and Patients, juli 2001. http://findarticles.com/p/articles/mi_m0ISW/is_2001_July/ai_76445678
2) ”Glutathione Therapy.” En intervju med David Perlmutter av Jill Selby. http://www.drhoffman.com/page.cfm/197
3) http://www.glutationexperts.com/benefits-glutation.html <http://www.glutathioneexperts.com/benefits-glutathione.html>
4) Klinghardt, Dietrich: Intervju med Dr Joseph Mercola, juni 2008. Tillgänglig via http://products.mercola.com/inner-circle/
5) Lewis, P.A.W., Klinghardt, D., Michel, J. ”Orally administered L-Glutation Therapy for Parkinsons patients.” 2002-05-23. Ej publicerad. http://nurseandi.com/pdf/ourgluta.pdf
6) Wang, H., Kuo, M.”Pyridoxine sometimes fails to be activated to pyridoxal phosphate.” Brain Research Bulletin, sept 2002, vol 58, nr 6:541
5) Klinghardt, Dietrich. ”A Comprehensive Review of Heavy Metal Detoxification and Clinical Pearls from 30 Years of Medical Practice.” http://www.klinghardtneurobiology.com/heavyMetalDetox.pdf
6) Katzenschlager R, Evans A et al. ”Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.” J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1672-7.
7) Derksen, Ann. “Some ways to reduce toxin exposure for your child.” http://www.klinghardtneurobiology.com/KlinghardtAutism2008Derksen.pdf
8) Manyam, Bala V. et al. ”Neuroprotective effects of the antiparkinson drug Mucuna pruriens.” Phytother Res. 2004 Sep;18(9):706-12.

Referenser till artikeln Parkinsons sjukdom
av
Mats Hansson

Benshlomo, Y, Whitehead, AS, Smith, GD: ”Parkinson's, Alzheimer's, and motor neurone disease - Clinical and pathological overlap may suggest common genetic and environmental factors.” British Medical Journal; 312 (7033) p724 Mar 23 1996
Chaturvedi, S, Ostbye, T, Stoessl, AJ, Merskey, H, Hachinski,V: ”Environmental exposures in elderly Canadians with Parkinson's disease.” Canadian Journal of Neurological Sciences; 22 (3) 232-234 aug 1995
Finkelstein, Y, Vardi, J, Kesten, MM & Hod, I: ”The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine.” Neurotoxicol 17 1996 291-296
Goldsmith, JR et al: ”Clustering of Parkinson's disease points to environmental etiology.” Arch Env Hlth 45 1990 88
Jenner, P, Dexter, DT, Sian, J, Schapira, AHV, Marsden, CD: ”Oxidative Stress as a Cause of Nigral Cell Death in Parkinson's Disease and Incidental Lewy Body Disease.” Annals of Neurology; 32 p S82-S87 1992
Jenner, P: ”Altered Mitochondrial Function, Iron Metabolism and Glutathione Levels in Parkinson's Disease.” Acta Neurologica Scandinavica; 87 p 6-13 1993
Mizuno,Y et al: ”Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.” Biochem Biophys Res Comm 163 1989 1450
Montastruc, JL, LIau, ME, Rascol, 0, Senard, JM: ”Druginduced parkinsonism: A review.” Fundamental & Clinical Pharmacology; 8 (4) p 293-306 1994
Morens, DM, Grandinetti, A, Reed, D, White, LR: ”Smoking-Associated Protection from Alzheimers and Parkinsons Disease.” Lancet; 343 (8893) p 356-357 Feb 5 1994
Ngim, C-H & Devathasan, G: ”Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease.” Neuroepidemiol 8 1989 128-141
Perry, TL et al: ”Alphatocopherol and betacarotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl- 1 ,2,3,6-tetrahydropyridine.” J Neurol Sci 8l 1987 321
Rybicki, BA et al: ”Parkinson's disease mortality and the industrial use of heavy metals in Michigan.” Movement Disord 8 1993 87-92
Schulz, JB, Henshaw, DR, Matthews, RT, Beal, MF: ”Coenzyme Q(l0) and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity.” Experimental Neurology; 132 (2) p 279-283 Apr 1995
Seidler, A, Hellenbrand, W, Robra, BP, Vieregge, P, Nischan, P, Joerg, J, Oertel, WIT, Ulm, G, Schneider, E: ”Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A casecontrol study in Germany.” Neurology; 46(5) p 1275-1284 May 1996 (BH37)
Simonian, NA, Coyle, JT:”Oxidative stress in neurodegenerative diseases.” Annual Review of Pharmacology and Toxicology; 36 p 83-106 1996
Vizuete, ML, Steffen, V, Machado, A, Cano, J: ”1-Methyl-4-Phenylpyridinium Has Greater Neurotoxic Effect After Selenium Deficiency Than After Vitamin E Deficiency in Rat Stratium.” European Journal of Pharmacology -Environmental Toxicology and Pharmacology Section; 270 (2-3) p 183-l87Apr 4 1994
Wagner, GC et al: ”Ascorbic acid reduces the dopamine depletion induced by MPTP.” Neuropharmacol 24 1985 1261
Wang,WZ, Fang, XH, Cheng, XM, Jiang, DH, Lin, ZJA: ”Case-Control Study on the Environmental Risk Factors of Parkinson's Disease in Tianjin, China.” Neuroepidemiology; 12 (4) p 209-218 Jul-aug 1993
Björklund, G: ”Parkinsons sykdom, kvikksolv og andre tungmetaller.” Tidsskr Nor Laegeforen, 1995 Feb 28; 115(6):757.
Zhang, ZX, Roman, GC: Worldwide Occurrence of Parkinson's Disease - An Updated Review. Neuroepidemiology; 12 (4) p195-208 Jul-aug 1993